Spinal muscular atrophy
Not recruitingStudy of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History
Study of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History
- Disease:Spinal muscular atrophy
- Substances:Taldefgrobep Alfa
Poland- Participants:0–17 years · 18–64 years
- Substances:Taldefgrobep Alfa
- Sponsor:Biohaven Pharmaceuticals Inc.










